CEO SUMMARY: When this hospital lab adopted molecular screening tests for Chlamydia trachomatis and Neisseria gonorrhoaea, physicians soon noticed a change in the rate of false positives. In researching the performance of the molecular assays compared to cultures, pathologists at this laboratory gained a better appreciation of how the introduction of a new molecular assay […]
For Molecular Tests, Evaluate All Factors
Changes in test specificity are likely to be noticed by clinicians
- By Robert Michel
- > From the Volume XII No. 8 - May 30, 2005 Issue
- Tags: dark report, diagnostic assays, hie, hospital laboratories, impac, infectious disease testing, ivd manufacturer, laboratories, laboratory director, molecular assay, molecular assays, molecular diagnostic, molecular diagnostic assays, molecular pathology, molecular testing, molecular tests, pathologists, pcr, the dark report, the laboratory
